NCT00002752View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1993

Primary Completion Date

January 31, 2003

Study Completion Date

March 31, 2010

Conditions
Brain and Central Nervous System TumorsMetastatic Cancer
Interventions
RADIATION

iodine I 131 monoclonal antibody 81C6

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER